miR-33a, for example, could suppress GEM resistance and cell proliferation in PC via targeting Pim-3 and inhibiting the Akt/GSK-3β/β-catenin signaling pathway (Liang et al., 2015b). Here, AKT1 is linked to pachyonychia congenita.